IFP Advisors’s ELITE PHARMACEUTICAL ELI Stock Holding History

IFP Advisors’s Portfolio ELI Stock Details ELI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200,000	Closed	-$7K	–	4665
2021 Q4	$7K	Hold	200,000	–	–	﹤0.01%	2387
2021 Q3	$9K	Hold	200,000	–	–	﹤0.01%	2348
2021 Q2	$10K	Hold	200,000	–	–	﹤0.01%	2230
2021 Q1	$12K	Hold	200,000	–	–	﹤0.01%	2082
2020 Q4	$10K	Buy	+200,000	New	+$10K	﹤0.01%	2093

Other funds holding ELI

BFAG

Blackston Financial Advisory Group The Villages, Florida $177M AUM 21.44% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

IFP Advisors's ELI Position: Q1 2022 in Review

IFP Advisors sold out of ELITE PHARMACEUTICAL (ELI) in Q1 2022, closing a stake of 200,000 shares — an estimated $7K sold.

IFP Advisors first reported a position in ELI in Q4 2020 and held it in 5 quarters. The position peaked at $12K in Q1 2021. 2 funds tracked by Wall St. Rank hold ELI as of Q1 2022.

IFP Advisors reported no remaining ELITE PHARMACEUTICAL position as of Q1 2022 after selling out during the quarter.
IFP Advisors sold 200,000 ELITE PHARMACEUTICAL shares in Q1 2022, an estimated $7K.
IFP Advisors first reported a position in ELITE PHARMACEUTICAL in Q4 2020 and held it in 5 quarters.
IFP Advisors's ELITE PHARMACEUTICAL position peaked at $12K in Q1 2021.
2 funds tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q1 2022.

Based on IFP Advisors's 13F filing for Q1 2022, filed 8 Aug 2022.